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http://dx.doi.org/10.1016/j.kjms.201Abstract Artificial urinary sphincter (AUS) is the gold standard treatment for urinary incon-
tinence owing to sphincter incompetence. We reviewed our experience in AUS implantation.
From 1995 to 2009, 19 patients underwent 25 AUS implantations performed by a single surgeon.
The cause of incontinence was sphincter incompetence, which was secondary to prostate
surgery, neurogenic bladder, radiation, and post-traumatic urethral lesion. Twenty-three pros-
theses were placed in the bulbar urethra for male patients: 11 AUS cuffs were placed through
the perineal approach and 12 through the penoscrotal approach. Two procedures were applied
over the bladder neck for the female patients. Through a retrospective review of charts, conti-
nence and complications were analyzed. The mean follow-up time was 50.0  42.9 months
(range: 2e146 months). There were 16 successful surgeries (64%), and these patients were free
from the need for a pad. In eight surgeries (32%), the devices were removed due to infection,
while one implantation (4%) was unsuccessful due to perforation into the bulbar urethra. There
was a statistically significant difference (p Z 0.024) in failure rates between patients who
received radiotherapy (100%) and other patients (22.7%). There was no statistically significant
difference in dry and revision rates (p > 0.05) between the perineal and penoscrotal approach.
Accordingly, over half of the patients with total incontinence benefitted from AUS implanta-
tion. In consideration of the high failure rate for patients receiving radiotherapy, caution
should be exercised in the use of implantation. Secondary implantation has a satisfactory
success rate in selected patients. The same success rate was noted for both perineal and pe-
noscrotal approaches.
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Table 1 Parameters of prosthesis in artificial urinary
sphincter implantation.
Parameter No. of procedures
Cuff location
Bladder neck (female) 2
Bulbar urethra (male) 23
Cuff size
4.0 cm 19
4.5 cm 4
5.0 cm 0
5.5 cm 2
Pressure of regulating balloon
61e70 cmH2O 24
51e60 cmH2O 1
Total 25
Table 2 Indications for artificial urinary sphincter
implantation according to etiologies of urinary
incontinence.
Indication No. of patients (%)
Neuropathic bladder dysfunction 4 (21%)
Spinal bifida 2
Spinal cord injury 1
Meningomyelocele 1
Urethral injury 6 (32%)
Radiotherapy 2 (10%)
Prostate cancer 1
Cervical cancer 1
Operation 7 (37%)
Radical prostatectomy 2
Transurethral resection
of the prostate (TURP)
4
Laser prostatectomy 1
Total 19
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The management of urinary incontinence remains chal-
lenging in neuropathic bladder as well as after prostate
surgery and traumatic urethral injury. Scott et al. [1] pre-
sented the first implantable artificial urinary sphincter
(AUS) in a patient with neuropathic bladder dysfunction.
Nowadays, the artificial sphincter is the gold standard
treatment for urinary incontinence due to sphincter
incompetence. To our knowledge, this series is the largest
in which AUS implantation has been performed by a single
surgeon in Taiwan. The objective of our study was to
analyze the outcome and complications of AUS implanta-
tion. We reviewed the success rate in different patient
groups with different etiologies of incontinence and
determined whether there were differences between
primary and secondary procedures and between perineal
and penroscrotal incision.
Materials and methods
Between 1995 and 2009, 19 patients underwent 25 AUS
implantations performed by a single surgeon at the medical
center. All patients received implantation with AMS800,
consisting of three basic components, a pressure regulating
balloon, an inflatable cuff, and a control pump. The cuff
was placed surrounding the bulbar urethra in males, and
surrounding the bladder neck in females. The inclusion
criteria of AUS implantation were persistent urinary
incontinence after urethral injury, prostate surgery or
radiation, and failure of conservative treatment for at least
9 to 12 months. The exclusion criteria were active urinary
tract infection, bladder hyperreflexia, vesicoureteral
reflux, or inability to manipulate the pump. During the
preoperative preparation, urine and blood examinations
were conducted to examine whether there was urinary
tract infection or other active systemic infection. The
prophylactic antibiotics regimen consisted of cefamezin
(1 g) preoperatively lasting for 3e5 days with cefamezin 1 g
Q8H postoperatively. Some patients (11 procedures carried
out before 2004) were placed in the lithotomy position, and
an incision was made over perineum for placement of cuff
and inguinal area for balloon placement. Other patients (12
procedures performed after 2004) were placed in the
supine position, and only one incision was made over the
penoscrotal area, which was done according to the method
described by Wilson et al. [2]. Female patients were placed
in the supine position and low abdominal incision was done
for implantation of all parts of the prosthesis. The cuff
diameters varied from 4 to 4.5 cm in male patients and
5.5 cm in female patients. The cuff size was decided by the
measurement of the diameter of bulbar urethra intra-
operatively. The pressure of the regulating balloon ranged
from 51 to 70 cmH2O.
Two patients received an additional AUS implantation
due to inadequate function of the first one. Two patients
with both urethral stricture (membranous urethra) and
incontinence received concomitant urethral stent (Uro-
Lume) and artificial sphincter implantation. One of them
also received penile prosthesis implantation for erectile
dysfunction (AMS 700 CX).Results
A total of 19 patients (mean age: 50.7  22.8 years; range:
15e78 years) received 25 AUS implantations and the char-
acter of prosthesis was shown in Table 1. The mean follow-
up time was 50.0  42.9 months (2e146 months). The cause
of incontinence in all cases was sphincter incompetence
while it have resulted from different etiologies. Specifi-
cally, the most frequent cause for AUS implantation was
sphincter injury after prostate surgery (37%) followed by
urethra trauma (32%) (Table 2).
Sixteen successful procedures (64%) with AUS remained
in situ and functioning (Table 3). However, two patients
received secondary cuff implantation due to insufficient
function of the first one at 12 and 28 months after primary
surgery, respectively. Both cases needed two cuffs working
together to become dry. Eight implantations (32%) were
removed because of refractory urinary infection or scrotal
abscess formation even after antibiotics treatment. There
was one implantation (4%) perforated the bulbar urethra
during cystoscopic examination for other urologic disor-
ders. The earliest presentation of infection was 35 days and
Table 3 Outcome of original artificial urinary sphincter by indication.
Outcome Overall Neuropathic
bladder
dysfunction
Urethral
injury
Radiation Operation
Radical
prostatectomy
TURP/laser
25 7 7 3 3 4/1
Infection, N (%) 8 (32) 3 (42.9) 0 3 (100) 0 2 (40)
Urethral erosion, N (%) 1 (4) 0 0 0 1 0
Delayed cuff
insufficiency, N (%)
2 (8) 1 (14.3) 1 (14.3) 0 0 0
Surgical removal, N (%) 9 (36) 3 (42.9) 0 3 (100) 1 (33.3) 2 (40)
Remain in situ
and function, N (%)
16 (64) 4 (57.1) 7 (100) 0 2 (66.7) 3 (60)
Artificial urinary sphincter implantation 159the latest was 93 months after implantation. The infection
rate in the radiation group was 100% while it was 22.7% in
the non-radiation group. There was a significant difference
between the two groups (p Z 0.024). Four subsequent
implantations were performed after removal of infective
prosthesis or urethra-perforated prosthesis 9 to 12 months
later. The success rate of the secondary AUS implantation
after removal of the infected one was 75% (3/4). There was
no statistically significant difference in dry (63.6% vs.
58.3%) and revision rates (9% vs. 8%) between perineal and
penoscrotal approaches (p > 0.05). Two patients who
received combined urethra stent and AUS implantation
were continent and urinating well at follow-up, but one
patient presented with vesicoureteral reflux after AUS
implantation which had not been evident before operation
(Fig. 1).
Discussion
In our series, the data showed the efficacy of AUS for urinary
incontinence. 64% of patients received a durable solutionFigure 1. Voiding cystourethrography (VCUG) of combined
artificial urinary sphincter (AUS) implantation (black arrow,
double control pump over scrotal area) and urethral stent
(white arrow) showing patent urethra canal but presence of
bilateral vesicoureteral reflux.to urinary incontinence due to neuropathic bladder, pros-
tate surgery or urethral injury. The infection rate (32%) was
higher than that in other series (4.5% to 25%) [3e6]; one
possible reason was that three procedures were applied to
patients who received radiotherapy for cervical or prostate
cancer in our series. Currently, radiotherapy is the manda-
tory therapy for cervical cancer and salvage therapy after
radical surgery. Treatment for prostate or cervical cancer
has the risk for urinary incontinence after radical surgery.
Under such circumstances, the surgeon should consider the
injury of sphincter competence because subsequent radio-
therapy is indicated for patients with these diseases. In our
series, the infection rate of prosthesis was 100% in the
radiotherapy group. The other series also reported high
infection in the radiation group (57e100%) [7e9]. The
insufficient sphincter mechanism was due to nerve
dysfunction or direct mechanical trauma in the urethral
injury and surgery group. The injury of the sphincter after
radiotherapy is caused by cell damage and tissue fibrosis.
Radiation also locally affects microcirculation and angio-
genesis and inhibits the work of the immune system and
immune response. This explains the high infection rate after
radiotherapy. However, the infection rate fell to 22.7% when
the patients receiving radiotherapy were excluded from the
statistical analysis, which is similar to other series. There-
fore, AUS implantation should be recommended cautiously
for patients with incontinence after radiotherapy.
Four patients received secondary implantation after
removal of the first infected prosthesis. The successful rate
of secondary implantation was 75%, which was not inferior
to the first implantation. The result of secondary implan-
tation was equivalent to that of the first implantation.
Ganesh et al. also showed the complete dry rate of 80%
versus 88% in primary and secondary operations, respec-
tively, and they concluded that the results of secondary
AUS implantation were similar to the first procedure [10]. In
our series, two patients received double AUS implantation
due to incompetence of the first prosthesis. We noted these
patients became totally continent with double AUS
implantation due to the contribution of both cuffs. The
other study also demonstrated the usefulness of double
prosthesis [11]. In addition to artificial sphincter implan-
tation, two patients received concomitant urethral stent
implantation for urethral stricture caused by urethral
injury. The other series also reported that different
mechanisms of implantation can work together effectively
in patients with urethral stricture and incontinence [12].
160 Y.-C. Shen, P.-H. ChiangWilson et al. [2] proposed that a single scrotal incision is
easier and faster than the traditional two-incision tech-
nique]. However, a multicenter study [13] advocated the
higher completely dry rate, and fewer subsequent tandem
cuff additions were noted in the perineal approach
compared to the penoscrotal approach. However, this study
is limited by the lack of standard surgical skills and selec-
tion of cuff size. Moreover, other omissions were noted in
the multicenter study, such as no record of operative time,
no consistent method to measure the success of AUS, and
unavailability of hospital records after 15 years. These
problems could be solved by all operations being conducted
by the same surgeon.
Conclusion
Our study indicated the efficacy of AUS in selected
patients. The prosthesis failure rate in patients receiving
radiotherapy was 100%. In light of this, meticulous consid-
eration should be given to patients with the above-
mentioned diseases undergoing surgery. The previous
infection of prosthesis or combination with urethral stric-
ture was not a contraindication for artificial sphincter
implantation. Finally, we would like to point out that the
penoscrotal approach for AUS implantation is easier and
faster than the perineal approach, with similar success
rates in both approaches.
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